BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38465550)

  • 1. Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
    Cohen E; Lheure C; Ingen-Housz-Oro S; Hotz C; Bettuzzi T; Chasset F; Descamps V; Deschamps L; Mahevas M; Terrier B; Sohier P; Guegan S; Kramkimel N; Darbord D; Chanal J; Oulès B; Aractingi S; Seta V; Dupin N
    Eur J Dermatol; 2023 Dec; 33(6):680-685. PubMed ID: 38465550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
    Paolino A; Galloway J; Birring S; Brex P; Larkin G; Patel A; Sado D; Murgatroyd F; Walsh S
    Clin Exp Dermatol; 2021 Aug; 46(6):1038-1045. PubMed ID: 33608920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.
    Marcoval J; Mañá J; Rubio M
    Clin Exp Dermatol; 2011 Oct; 36(7):739-44. PubMed ID: 21790725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin manifestations of sarcoidosis.
    Mañá J; Marcoval J
    Presse Med; 2012 Jun; 41(6 Pt 2):e355-74. PubMed ID: 22579238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous sarcoid with varied morphology associated with hypercalcaemia and renal impairment.
    Miida H; Ito M
    Clin Exp Dermatol; 2009 Dec; 34(8):e656-9. PubMed ID: 19538188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy].
    Meyersburg D; Schön MP; Bertsch HP; Seitz CS
    Hautarzt; 2011 Sep; 62(9):691-5. PubMed ID: 21656110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological analysis of specific lesions of cutaneous sarcoidosis in Korean patients.
    Jung YJ; Roh MR
    J Dermatolog Treat; 2011 Feb; 22(1):11-7. PubMed ID: 20524878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate for the treatment of patients with chronic cutaneous sarcoidosis: 4 cases].
    Gary A; Modeste AB; Richard C; Jubert C; Majour F; Nouvet G; Remond B; Joly P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):659-62. PubMed ID: 16230915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydroxychloroquine for non-severe extra-pulmonary sarcoidosis].
    Jamilloux Y; El Jammal T; Bert A; Sève P
    Rev Med Interne; 2022 Jul; 43(7):406-411. PubMed ID: 35660263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas.
    Jones E; Callen JP
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):487-9. PubMed ID: 2212149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis.
    Tong C; Zhang X; Dong J; He Y
    Int J Clin Exp Pathol; 2014; 7(1):372-7. PubMed ID: 24427359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department.
    Collin B; Rajaratnam R; Lim R; Lewis H
    Clin Exp Dermatol; 2010 Mar; 35(2):131-4. PubMed ID: 19594768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous manifestations of sarcoidosis].
    Descamps V; Bouscarat F
    Ann Dermatol Venereol; 2016 Jan; 143(1):39-50. PubMed ID: 26804434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous sarcoidosis in Tunisia.
    Khaled A; Souissi A; Zeglaoui F; Mokhtar I; Ezzine N; Fazaa B; Kamoun MR
    G Ital Dermatol Venereol; 2008 Jun; 143(3):181-5. PubMed ID: 18833060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual manifestation of cutaneous sarcoidosis: a case report of morpheaform sarcoidosis.
    Vasaghi A; Kalafi A
    Acta Med Iran; 2012; 50(9):648-51. PubMed ID: 23165817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous sarcoidosis: a dermatologic masquerader.
    Katta R
    Am Fam Physician; 2002 Apr; 65(8):1581-4. PubMed ID: 11989634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic management of pulmonary sarcoidosis.
    Fazzi P
    Am J Respir Med; 2003; 2(4):311-20. PubMed ID: 14719997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous sarcoidosis: clinicopathologic study of 76 patients from Lebanon.
    Ishak R; Kurban M; Kibbi AG; Abbas O
    Int J Dermatol; 2015 Jan; 54(1):33-41. PubMed ID: 25265873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.